Prospective Assessment in Newborns for Diabetes Autoimmunity

Completed

• Conditions: Autoimmunity; Type 1 Diabetes

• Registration Number: NCT00649246
• Lead Sponsor: Augusta University

Brief Summary

This is an observational study designed to help researchers understand the genetics and pathogenesis of type 1 diabetes, and to identify biomarkers for disease and disease complication prediction.

Detailed Description

This study is designed to identify people who are at risk for developing type 1 diabetes, based on their genetics, family history and autoimmunity status, and to understand the role genetics plays in the development of the complications associated with type 1 diabetes in patients already affected by type 1 diabetes.

Study Timeline

• Study Start: 1997-07
• Study First Submitted: 2008-03-28
• Study First Submitted QC: 2008-03-28
• Study First Posted: 2008-04-01
• Primary Completion: 2010-08
• Study Completion: 2010-08
• Status Verified: 2018-03
• Last Update Submitted: 2018-03-26
• Last Update Posted: 2018-03-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25055

Inclusion Criteria

all are welcome -

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
autoantibodies against the pancreas and type 1 diabetes	50 years

Secondary Outcome Measures

Name	Time	Method
Risk factors for type 1 diabetes	50 years

Trial Locations

Locations (3)

Medical University of South Carolina; 🇺🇸 Charleston, South Carolina, United States

University of Florida; 🇺🇸 Gainesville, Florida, United States

University of South Carolina; 🇺🇸 Columbia, South Carolina, United States